Yumanity Therapeutics (FRA:8IY) Other Income (Expense) : €-3.72 Mil (TTM As of Sep. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Other Income (Expense)?

Yumanity Therapeutics's other income expense for the Yumanity Therapeutics's pretax income for the three months ended in Sep. 2022 was €0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2022 was €-3.72 Mil.

Yumanity Therapeutics Other Income (Expense) Historical Data

The historical data trend for Yumanity Therapeutics's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Other Income (Expense) Chart

Yumanity Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Other Income (Expense)

-0.45

-23.23

1.00

Yumanity Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Other Income (Expense)	Get a 7-Day Free Trial							-	-	-3.72	-	-

Yumanity Therapeutics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.72 Mil.

Yumanity Therapeutics (FRA:8IY) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Yumanity Therapeutics (FRA:8IY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Guest Street, Suite 4410, Boston, MA, USA, 02135

Website

https://www.yumanity.com

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines